The Net Margin of China Regenerative Medicine International Ltd (8158.HK) is -154.99%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
Date | Value |
---|---|
2023-12-31 | -154.99% |
2022-12-31 | 1.97% |
2021-12-31 | 4.72% |
2020-12-31 | -221.94% |
2019-12-31 | -2039.79% |
2018-12-31 | -1636.01% |
2017-12-31 | -31.47% |
2017-04-30 | -51.68% |
2016-04-30 | -687.91% |
2015-04-30 | -8878.17% |